Published in Yonsei Med J on July 01, 2014
Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms. Int J Environ Res Public Health (2015) 0.79
Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev (2012) 4.39
Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis (2007) 2.01
Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli. Int J Antimicrob Agents (2005) 1.90
Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes. Emerg Infect Dis (2007) 1.82
Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system. Antimicrob Agents Chemother (2000) 1.65
Stenotrophomonas maltophilia D457R contains a cluster of genes from gram-positive bacteria involved in antibiotic and heavy metal resistance. Antimicrob Agents Chemother (2000) 1.63
Plasmid-mediated quinolone resistance: an update. J Infect Chemother (2010) 1.48
In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods. J Antimicrob Chemother (2004) 1.47
Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect (2004) 1.45
Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol (2009) 1.34
Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections. Antimicrob Agents Chemother (2010) 1.32
Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. Antimicrob Agents Chemother (1996) 1.28
Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains. Antimicrob Agents Chemother (2001) 1.24
Stenotrophomonas maltophilia drug resistance. Future Microbiol (2009) 1.22
Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother (2000) 1.15
Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996-2009. Eur J Clin Microbiol Infect Dis (2010) 1.15
Stenotrophomonas maltophilia: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital. Clin Microbiol Infect (2005) 1.10
SmQnr contributes to intrinsic resistance to quinolones in Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2009) 1.09
Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review. J Hosp Infect (2012) 1.08
Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment. Expert Rev Anti Infect Ther (2011) 1.07
Stenotrophomonas maltophilia--the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study. J Infect (2012) 1.05
Structural and functional analysis of SmeT, the repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF. J Biol Chem (2009) 1.03
Novel variants of the Smqnr family of quinolone resistance genes in clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother (2010) 0.95
Increased incidence of class 1 integrons in trimethoprim/sulfamethoxazole-resistant clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother (2007) 0.94
Emergence of ofloxacin-resistant Citrobacter freundii and Pseudomonas maltophilia after ofloxacin therapy. J Antimicrob Chemother (1987) 0.93
Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy. Transpl Infect Dis (2012) 0.90
Risk factors for mortality in patients with nosocomial Stenotrophomonas maltophilia pneumonia. Infect Control Hosp Epidemiol (2009) 0.87
Heterogeneous spectrum of CFTR gene mutations in Korean patients with cystic fibrosis. Korean J Lab Med (2011) 0.87
Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer. Cancer (2007) 0.86
Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case-controlled study. J Infect Chemother (1999) 0.81
Post-antibiotic effect (PAE) of moxifloxacin in multidrug-resistant Stenotrophomonas maltophilia. Int J Antimicrob Agents (2010) 0.79
Differential epigenetic compatibility of qnr antibiotic resistance determinants with the chromosome of Escherichia coli. PLoS One (2012) 0.78
Increase in the Prevalence of Carbapenem-Resistant Acinetobacter Isolates and Ampicillin-Resistant Non-Typhoidal Salmonella Species in Korea: A KONSAR Study Conducted in 2011. Infect Chemother (2014) 1.02
The changes of PCR ribotype and antimicrobial resistance of Clostridium difficile in a tertiary care hospital over 10 years. J Med Microbiol (2014) 0.97
Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa. Infect Chemother (2015) 0.86
Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa in Korea. Infect Chemother (2015) 0.86
Metabolic Complications among Korean Patients with HIV Infection: The Korea HIV/AIDS Cohort Study. J Korean Med Sci (2017) 0.85
Primary lymphoma of bone--survival and prognosis. Korean J Intern Med (2002) 0.83
Xpert CARBA-R Assay for the Detection of Carbapenemase-Producing Organisms in Intensive Care Unit Patients of a Korean Tertiary Care Hospital. Ann Lab Med (2016) 0.83
Evaluation of a rapid membrane enzyme immunoassay for the simultaneous detection of glutamate dehydrogenase and toxin for the diagnosis of Clostridium difficile infection. Ann Lab Med (2014) 0.82
Campylobacter hyointestinalis isolated from a human stool specimen. Ann Lab Med (2015) 0.82
Detection of Carbapenemases in Clinical Enterobacteriaceae Isolates Using the VITEK AST-N202 Card. Infect Chemother (2015) 0.81
In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment. Yonsei Med J (2015) 0.80
Prediction of Putative Resistance Islands in a Carbapenem-Resistant Acinetobacter baumannii Global Clone 2 Clinical Isolate. Ann Lab Med (2016) 0.80
Risk factors for the acquisition of carbapenem-resistant Escherichia coli at a tertiary care center in South Korea: a matched case-control study. Am J Infect Control (2014) 0.79
Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital. Ann Lab Med (2014) 0.79
Clinical factors associated with hepatitis A virus seropositivity in HIV-infected adults living in a country with an epidemiologic shift for hepatitis A virus infection. J Korean Med Sci (2012) 0.78
Anaerobic Bacteremia: Impact of Inappropriate Therapy on Mortality. Infect Chemother (2016) 0.78
Association between HbA1c and carotid atherosclerosis among elderly Koreans with normal fasting glucose. PLoS One (2017) 0.78
Comparison of E,E-Farnesol Secretion and the Clinical Characteristics of Candida albicans Bloodstream Isolates from Different Multilocus Sequence Typing Clades. PLoS One (2016) 0.77
The effect of bortezomib on expression of inflammatory cytokines and survival in a murine sepsis model induced by cecal ligation and puncture. Yonsei Med J (2015) 0.77
Mechanisms of ertapenem resistance in Enterobacteriaceae isolates in a tertiary university hospital. J Investig Med (2016) 0.76
Evidence-based guidelines for fall prevention in Korea. Korean J Intern Med (2017) 0.75
Increasing Incidence of High-Level Tetracycline-Resistant Neisseria gonorrhoeae due to Clonal Spread and Foreign Import. Yonsei Med J (2016) 0.75
Opportunistic diseases among HIV-infected patients: a multicenter-nationwide Korean HIV/AIDS cohort study, 2006 to 2013. Korean J Intern Med (2016) 0.75
Long Pentraxin 3 as a Predictive Marker of Mortality in Severe Septic Patients Who Received Successful Early Goal-Directed Therapy. Yonsei Med J (2017) 0.75
Change in Renal Function among HIV-Infected Koreans Receiving Tenofovir Disoproxil Fumarate-Backbone Antiretroviral Therapy: A 3-Year Follow-Up Study. Yonsei Med J (2017) 0.75
Burkholderia Sepsis in Children as a Hospital-Acquired Infection. Yonsei Med J (2016) 0.75
Persistent Bordetella petrii Infection Related to Bone Fractures. Ann Lab Med (2016) 0.75
Disk Carbapenemase Test for the Rapid Detection of KPC-, NDM-, and Other Metallo-β-Lactamase-Producing Gram-Negative Bacilli. Ann Lab Med (2016) 0.75
Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX™) in Korean Adults. J Korean Med Sci (2015) 0.75
Fecal Calprotectin Level Reflects the Severity of Clostridium difficile Infection. Ann Lab Med (2017) 0.75
Evaluation of VITEK mass spectrometry (MS), a matrix-assisted laser desorption ionization time-of-flight MS system for identification of anaerobic bacteria. Ann Lab Med (2014) 0.75
Colistin Resistance in Escherichia coli Isolates From Patients With Bloodstream Infection in Korea. Ann Lab Med (2017) 0.75
Identification of Acinetobacter Species Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. Ann Lab Med (2016) 0.75
First Case Report of Human Infection With Ochrobactrum tritici Causing Bacteremia and Cholecystitis. Ann Lab Med (2016) 0.75
Substantial Improvement in Nontuberculous Mycobacterial Identification Using ASTA MicroIDSys Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry with an Upgraded Database. Ann Lab Med (2022) 0.75
Serotype Distribution and Antimicrobial Resistance of Isolates in Korea between 2016 and 2017. Ann Lab Med (2022) 0.75
First Case of Bacteremia in an Immunocompromised Patient in Korea. Ann Lab Med (2019) 0.75
Molecular epidemiology and resistome analysis of multidrug-resistant ST11 Klebsiella pneumoniae strain containing multiple copies of extended-spectrum β-lactamase genes using whole-genome sequencing. New Microbiol (2017) 0.75
Clinical Differences in Patients Infected with and Antimicrobial Susceptibility of Isolates Recovered at a Tertiary-Care Hospital in Korea. Ann Lab Med (2021) 0.75
The blaOXA-23-associated transposons in the genome of Acinetobacter spp. represent an epidemiological situation of the species encountering carbapenems. J Antimicrob Chemother (2017) 0.75
Extensively Drug-Resistant Escherichia coli Sequence Type 1642 Carrying an IncX3 Plasmid Containing the blaKPC-2 Gene Associated with Transposon Tn4401a. Ann Lab Med (2018) 0.75
Abrupt Increase in Rate of Imipenem Resistance in Acinetobacter baumannii Complex Strains Isolated from General Hospitals in Korea and Correlation With Carbapenem Administration During 2002-2013. Ann Lab Med (2018) 0.75
Increasing Incidence of Listeriosis and Infection-associated Clinical Outcomes. Ann Lab Med (2018) 0.75
Serotype Distribution and Antimicrobial Resistance of Invasive and Noninvasive Isolates in Korea between 2014 and 2016. Ann Lab Med (2019) 0.75
Adjustment of Modified Carbapenem Inactivation Method Conditions for Rapid Detection of Carbapenemase-Producing . Ann Lab Med (2020) 0.75
Whole genome and transcriptome analysis reveal MALDI-TOF MS and SDS-PAGE have limited performance for the detection of the key outer membrane protein in carbapenem-resistant Klebsiella pneumoniae isolates. Oncotarget (2017) 0.75
Massilia varians Isolated from a Clinical Specimen. Infect Chemother (2017) 0.75